Total Payments
$1,036
2022 Payments
$3.82
Companies
6
Transactions
21
Medicare Patients
5,844
Medicare Billing
$578,843
Payment Breakdown by Category
Travel$653.11 (63.0%)
Food & Beverage$271.39 (26.2%)
Education$111.77 (10.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $653.11 | 2 | 63.0% |
| Food and Beverage | $271.39 | 13 | 26.2% |
| Education | $111.77 | 6 | 10.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $823.52 | 5 | $0 (2019) |
| Astellas Pharma US Inc | $181.36 | 12 | $0 (2019) |
| Rochester Medical Corporation | $19.48 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $3.82 | 1 | Travere Therapeutics, Inc. ($3.82) |
| 2019 | $835.59 | 6 | NeoTract Inc. ($823.52) |
| 2018 | $170.60 | 12 | Astellas Pharma US Inc ($169.29) |
| 2017 | $26.26 | 2 | Rochester Medical Corporation ($19.48) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/14/2022 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 06/14/2019 | NeoTract Inc. | UroLift (Device) | Travel and Lodging | In-kind items and services | $206.51 | General |
| Category: Interventional Urology | ||||||
| 06/14/2019 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Interventional Urology | ||||||
| 06/14/2019 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Interventional Urology | ||||||
| 06/13/2019 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $140.35 | General |
| Category: Interventional Urology | ||||||
| 05/10/2019 | NeoTract Inc. | UroLift (Device) | Travel and Lodging | In-kind items and services | $446.60 | General |
| Category: Interventional Urology | ||||||
| 02/21/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $7.78 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $1.80 | General |
| Category: ONCOLOGY | ||||||
| 09/21/2018 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $1.31 | General |
| Category: Kidney Stones | ||||||
| 08/01/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.99 | General |
| 05/21/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $7.07 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2017 | Rochester Medical Corporation | BMD-Magic3 Catheter (Device) | Food and Beverage | Cash or cash equivalent | $19.48 | General |
| Category: Urology | ||||||
| 02/08/2017 | Endocare, Inc. | Endocare Cryocare System (Medical Supply) | Food and Beverage | Cash or cash equivalent | $6.78 | General |
| Category: Cryo Probe | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 30 | 2,692 | 7,743 | $917,290 | $262,617 |
| 2020 | 39 | 3,152 | 9,679 | $1.2M | $316,226 |
Total Patients
5,844
Total Services
17,422
Medicare Billing
$578,843
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 19 | 4,322 | $134,942 | $72,012 | 53.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 566 | 719 | $183,345 | $61,772 | 33.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 26 | 199 | $44,628 | $29,223 | 65.5% |
| 52601 | Electro-removal of prostate through bladder canal (urethra) with control of bleeding using an endoscope | Facility | 2021 | 27 | 27 | $81,540 | $15,487 | 19.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 72 | 78 | $26,910 | $10,118 | 37.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 58 | 58 | $29,000 | $8,901 | 30.7% |
| 55700 | Biopsy of prostate gland | Office | 2021 | 39 | 39 | $26,715 | $7,574 | 28.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 66 | 66 | $26,070 | $6,567 | 25.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2021 | 288 | 339 | $33,900 | $6,176 | 18.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 81 | $13,770 | $5,001 | 36.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 80 | 83 | $48,555 | $4,990 | 10.3% |
| 52356 | Crushing of stone in urinary duct (ureter) with stent using an endoscope | Facility | 2021 | 12 | 14 | $14,280 | $4,483 | 31.4% |
| 76872 | Ultrasound of pelvic region through rectum | Office | 2021 | 38 | 38 | $12,920 | $4,326 | 33.5% |
| 52630 | Removal of remaining or regrown prostate tissue with control of bleeding using an endoscope | Facility | 2021 | 13 | 13 | $15,470 | $4,090 | 26.4% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2021 | 11 | 40 | $13,600 | $2,766 | 20.3% |
| 99218 | Hospital observation care, typically 30 minutes | Facility | 2021 | 32 | 33 | $7,920 | $2,520 | 31.8% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 39 | 42 | $18,060 | $1,982 | 11.0% |
| 52441 | Insertion of implant in bladder canal (urethra) within prostate gland using an endoscope, single implant | Facility | 2021 | 12 | 12 | $35,760 | $1,921 | 5.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 437 | 531 | $13,275 | $1,676 | 12.6% |
| 52442 | Insertion of implant in bladder canal (urethra) within prostate gland using an endoscope, each additional implant | Facility | 2021 | 12 | 39 | $88,920 | $1,591 | 1.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 345 | 441 | $8,820 | $1,304 | 14.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 133 | 152 | $7,600 | $1,043 | 13.7% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 25 | 41 | $4,920 | $1,025 | 20.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $4,140 | $997.31 | 24.1% |
| 51701 | Insertion of temporary bladder catheter | Office | 2021 | 21 | 26 | $5,200 | $932.00 | 17.9% |
About Dr. John Sislow, M.D
Dr. John Sislow, M.D is a Urology healthcare provider based in Walla Walla, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245204007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Sislow, M.D has received a total of $1,036 in payments from pharmaceutical and medical device companies, with $3.82 received in 2022. These payments were reported across 21 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($653.11).
As a Medicare-enrolled provider, Sislow has provided services to 5,844 Medicare beneficiaries, totaling 17,422 services with total Medicare billing of $578,843. Data is available for 2 years (2020–2021), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Walla Walla, WA
- Active Since 02/16/2006
- Last Updated 11/27/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1245204007
Products in Payments
- UroLift (Device) $823.52
- XTANDI (Drug) $91.37
- BMD-Magic3 Catheter (Device) $19.48
- Endocare Cryocare System (Medical Supply) $6.78
- Thiola (Drug) $3.82
- (815) Thiola (Drug) $1.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.